Skip to content

News & updates

Asia’s Changemakers: Heeding The Call For COVID-19 Testing
MiRXES — A game changer in microRNA applications
Singapore clears new SARS-CoV-2 test for clinical use
MiRXES to mass-produce SARS-CoV-2 test kits
Singapore at the forefront of global microRNA research and application
Timely guidance for MiRXES from Pro-Enterprise Panel
Blood test for stomach cancer first step to ending all cancer deaths by 2048
A Singapore startup has a real shot at stamping out cancer deaths
Seniors get tested for stomach cancer at free screening in Teck Ghee
Singapore’s Ark raises US$40M to expand its non-invasive cancer detection technologies in Asia
Medtech startup Ark clinches $55.03m funding
Singapore team gets funding to ‘eliminate late-stage cancer’
Medtech firm Ark launched with US$40m Series A funding
Promising biomedical start-ups in Singapore – MiRXES
MiRXES to collaborate with Beth Israel Deaconness Medical Centre
MiRXES co-founder Zhou Lihan’s entrepreneurial journey
Mirxes collaborates with J&J to develop miRNA test for lung cancer
MiRXES, J&J and Janssen unites for early detection of lung cancer
MiRXES aims to make cancer tests more accessible
Venturecraft invests in MiRXES